MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA (Darmstadt, Germany), announced a €300 million in South Korea. The investment goes toward a new bioprocessing production center in Daejon, South Korea. It marks the largest investment by the company’s life science business sector in Asia-Pacific to date. The company expects the investment to…
MilliporeSigma introduces excipient with sugar-like flavor
The Neotame Emprove Essential NF excipient from MilliporeSigma (Burlington, Massachusetts) is a high-intensity sweetener that can be used to mask the bitter flavor of active pharmaceutical ingredients. Neotame Emprove Essential NF is a N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine-1-methyl ester. MilliporeSigma notes that the product is a potent, synthetic sweetener with a sugar-like flavor but is between 8,000 and 13,000…